약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 4. Baseline characteristics of colorectal cancer subjects
Sub analysis (Colorectal) Control group N=2641 (%) Parkinson’s disease group N=2641 (%) p-value
Sex 1.00
Male 1409 (53.35) 1409 (53.35)
Female 1232 (46.65) 1232 (46.65)
Age, years (mean±SD) 71.69±8.65 71.62±8.89 0.78
Charlson Comorbidity Index (mean±SD) 3.84±2.67 4.79±3.07 <0.001
Comorbidities
Myocardial infarction 113 (4.28) 145 (5.49) 0.041
Congestive heart failure 498 (18.86) 572 (21.66) 0.011
Peripheral vascular disease 901 (34.12) 1080 (40.89) <0.001
Cerebrovascular disease 605 (22.91) 1014 (38.39) <0.001
Dementia 419 (15.87) 750 (28.40) <0.001
Chronic pulmonary disease 1519 (57.52) 1726 (65.35) <0.001
Rheumatic disease 288 (10.90) 354 (13.40) 0.0054
Peptic ulcer disease 1410 (53.39) 1607 (60.85) <0.001
Mild liver disease 1458 (55.21) 1533 (58.05) 0.037
Diabetic without chronic complications 1387 (52.52) 1549 (58.65) <0.001
Mild renal disease 237 (8.97) 277 (10.49) 0.063
Diabetic with chronic complications 466 (17.64) 631 (23.89) <0.001
Hemiplegia or paraplegia 67 (2.54) 155 (5.87) <0.001
Severe liver disease 20 (0.76) 49 (1.86) 0.0004
Severe renal disease 95 (3.60) 166 (4.39) 0.140
Yakhak Hoeji 2024;68:371-7 https://doi.org/10.17480/psk.2024.68.5.371
© 2024 Yakhak Hoeji